Explore evidence

1.25 per_100_person-yearsHIV incidence was 1.25 per 100 person-years among women who declined PrEP.

KenyaVIH/sidapublished 2026PLoS medicinePubMeddocument of 10 observations

69.3 relative_utilityClinically stable people living with HIV preferred receiving care at a health facility over home-delivery or a community meeting point, with relative utilities of 69.3, -16.2, and -53.1, respectively.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 6 observations

89.3 %Fingerprint technology achieved a sensitivity of 89.3% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

92.9 %Among virally suppressed AYPLHIV at baseline enrolled in Operation Triple Zero (OTZ), 92.9% of males sustained viral load suppression (VLS).

KenyaVIH/sidapublished 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 9 observations

27 %Among 10,096 adolescents and young adults aged 10–24 years on antiretroviral treatment for more than 6 months in 99 HIV clinics in Kenya between January 2016 and December 2017, the proportion with unsuppressed viral load at last test was 27%.

KenyaVIH/sidaobserved 2016–2017published 2020AIDS (London, England)PubMeddocument of 3 observations

0.42 pointsThe agricultural livelihood intervention resulted in a significant decrease of 0.42 points in internalized HIV stigma over 24 months.

KenyaVIH/sidaobserved 24 monthspublished 2024AIDS (London, England)PubMeddocument of 6 observations

84 %There was a high linkage to care and treatment services (84%) among those who tested reactive for HIV at endline.

KenyaVIH/sidapublished 2023Gates open researchPubMeddocument of 4 observations

32.9 USDThe average cost of an adolescent HIV care visit was 32.9 USD in the ATP intervention arm.

KenyaVIH/sidapublished 2024PloS onePubMeddocument of 4 observations

6.6 %HIV prevalence among adult women in the general population in Kenya is 6.6%.

KenyaVIH/sidapublished 2024PloS onePubMeddocument of 6 observations

5.22 relative_riskMaternal non-disclosure of HIV status to partner(s) was associated with a relative risk of 5.22 for infant HIV positivity at 6 months.

KenyaVIH/sidaobserved 6 monthspublished 2023European Journal of Public HealthOpenAlexdocument of 7 observationsDOI 10.1093/eurpub/ckad160.824

4 %Verifiable positive HIV serology was identified in 47 cases (27% of the 171 cases meeting strength-of-evidence criteria), corresponding to an absolute seroprevalence rate of 4% among all 1,200 cancer registered cases.

Kenyacancer (non précisé) · VIH/sidaobserved August 1 to October 31, 2011published 2014PloS oneeurope_pmcdocument of 4 observations

44.7 %The age-specific adjusted HIV prevalence among people who inject drugs who initiated injecting at ages 11–19 years was 44.7%.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 17 observations

3,501 clientsA total of 3501 clients eligible for ≥3MMD were included in the analysis.

KenyaVIH/sidaobserved between July 2017 and December 2019published 2023AIDS (London, England)PubMeddocument of 5 observations

2.5 %HIV prevalence was 2.5% overall among 3,061 adolescent boys and girls aged 15–19 residing in urban informal settlements in Kisumu.

KenyaVIH/sidapublished 2023AIDS education and prevention : official publication of the International Society for AIDSPubMeddocument of 2 observations

633 individualsThe analysis included 633 individuals who were lost to follow-up (LTFU) and 13,098 individuals retained in care.

KenyaVIH/sidaobserved October 1, 2016, to June 30, 2017published 2021AIDS research and human retrovirusesPubMeddocument of 6 observations

26.5 %Among men who have sex with men living with HIV in Kenya, 26.5% of those who solely met partners via virtual sites (VMSM) were on antiretroviral treatment.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

32 %In Nairobi, the increase in knowledge of HIV status attributable to DREAMS was 32% among adolescent girls and young women aged 15–17 years in 2017.

KenyaVIH/sidaobserved 2017published 2022Journal of epidemiology and community healthPubMeddocument of 6 observations

1 %Among 423 HIV-negative Kenyan men who have sex with men and transgender women, daily PrEP was the least preferred HIV prevention method, chosen by 1% in pairwise comparisons.

KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 9 observations

1.58 incidence_rate_ratioCommunity outreach was associated with an incidence rate ratio of 1.58 for identification of adolescents with HIV.

KenyaVIH/sidaobserved October 2015 to September 2016published 2022AIDS carePubMeddocument of 16 observations

496 cells/μLThe median CD4 count among the 49 participants was 496 cells/μL.

KenyaVIH/sidaobserved 2016-2018published 2022Microbiology spectrumPubMeddocument of 5 observations

1.1 aRRReceiving DTG vs. EFV-based ART regimen was associated with a higher likelihood of enrollment in ≥3MMD (adjusted relative risk: 1.10; 95% confidence interval: 1.05–1.15).

KenyaVIH/sidaobserved between July 2017 and December 2019published 2023AIDS (London, England)PubMeddocument of 5 observations

69 %Among 617 pregnant women with high HIV risk scores in Kenya, 69% declined PrEP.

KenyaVIH/sidapublished 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

12.3 %At baseline, HIV prevalence was 12.3% in control communities.

KenyaVIH/sidapublished 2020AIDS (London, England)PubMeddocument of 8 observations

52.7 %Among children and adolescents living with HIV in central Kenya, 52.7% were girls.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

7.7 %Among 671 participants, 52 (7.7%) were living with HIV.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 8 observations